Skip to main content

Table 4 CI surgery in 10 patients with MYH9 -RD

From: Cochlear implantation is safe and effective in patients with MYH9-related disease

Patient/family CI side Surgical approach1 Device Prophylaxis for bleeding Intraoperative bleeding2 Postoperative bleeding
1/1 R Round window Digisonic SP (Neurelec) Platelet apheresis, 1U pre + 1U post 1 None
2/2 R Round window Nucleus CI24RE (Cochlear) Platelet apheresis, 1U pre 3 None
3/3 L Round window Maestro Concerto Flex 28 (Med-el) Platelet apheresis, 1U pre + 1U post 1 None
4/4 R Round window Nucleus Freedom CI24RE (Cochlear) None 1 None
5/5 L + R Cochleostomy Nucleus Mini22 (Cochlear) nd 1 None
6/6 L Round window Digisonic SP (Neurelec) Platelet apheresis, 1U pre phenocompatible 1 None
7/7 L Cochleostomy Nucleus CI512 (Cochlear) None 1 None
8/7 R Cochleostomy Nucleus CI24R (CA) (Cochlear) None 2 Hematoma at the site of surgical wound
9/7 L Cochleostomy Mini-system 22 CI22M (Cochlear) None 1 None
10/8 R Round window Maestro Concerto Flex 28 (Med-el) Tranexamic acid 1 g i.v. pre, then 1500 mg/day p.o. post for 7 days 1 None
  1. Notes: 1 = use of cochleostomy or round window for positioning of the device. 2 = Bleeding score adapted according to Boezaart et al., [24]: Grade 1: minimal suction. Grade 2: slight bleeding, infrequent suction. Grade 3: brisk bleeding, frequent suction. Grade 4: strong bleeding, bleeding covers surgical field after removal of suction before instrument can perform manoeuver; Grade 5: uncontrolled bleeding, bleeding out of mastoid cavity on removal of suction. Abbreviations: pre = preoperative, post = postoperatively.